Skip to content

Study · Animal study (in vivo) · equine · 2023

1 result

Synovial fluid mitochondrial DNA concentration reflects the degree of cartilage damage after naturally occurring articular injury.

Seewald LA, Sabino IG, Montney KL, Delco ML

Osteoarthritis and cartilage6 Apr 2023Cited by 14 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In horses with impact injury to articular cartilage, intraarticular SS‑31 mitigated impact-induced mtDNA release.

    In plain wordsIn horses with joint cartilage injury, SS‑31 reduced the release of mitochondrial DNA into joint fluid.

    Outcome
    DecreaseImpact-induced synovial fluid mtDNA release
    Study

    equinen: not reported in source

    In vivo mechanical impact of equine articular cartilage
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    Dose not stated · intraarticularAs given in this study (equine).

    Source sentences

    Summary
    Finally, impact-induced mtDNA release was mitigated by mitoprotective treatment.
    2 context sentences
    Summary · context
    In our in vivo model, one group was treated with an intraarticular injection of the mitoprotective peptide SS-31 following cartilage injury
    Summary · context
    We measured mtDNA release using four models of osteoarthritis: in vitro interleukin-1β stimulation of cultured equine chondrocytes, ex vivo mechanical impact of bovine cartilage explants, in vivo mechanical impact of equine articular cartilage, and naturally occurring equine intraarticular fracture.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.